Minimal residual disease detection with tumor-specific CD160 correlates with event-free survival in chronic lymphocytic leukemia. (Q35040222)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q56863233)
(Q73267805)
(P275) (Q24082749)
(P304) e273
(P407) (Q1860)
(P478) 5
(P577) Friday, January 23, 2015
(P921) (Q715347)
(P1433) (Q2464036)
(P1476) "Minimal residual disease detection with tumor-specific CD160 correlates with event-free survival in chronic lymphocytic leukemia" (language: en)
(P2093) T W Farren
M Fanous
M G Macey
F Wright
A Prentice
A Nathwani
S G Agrawal
(P2860) (Q37625491)
(Q37625487)
(Q37634897)
(Q24616084)
(Q35845098)
(Q35685644)
(Q35606345)
(Q35566906)
(Q28140129)
(Q36592108)
(Q41532721)
(Q43286767)
(Q44688907)
(Q45287934)
(Q46825515)
(Q44539030)
(Q52854227)
(Q77788775)
(Q83441006)
(Q77637344)
(Q70245241)
(P6216) (Q50423863)
other details
description scientific article

External Links